SCHEMBL4379701

SCHEMBL4379701

[CH2]CNc1nc(NCc2ccc(F)c(Cl)c2)ccc1[N+](=O)[O-]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.46
ALDH1A1 P00352 3/20 0.42
DYRK1A Q13627 1/20 0.42
CLK4 Q9HAZ1 1/20 0.42
POLB P06746 1/20 0.41
SIRT5 Q9NXA8 1/20 0.40
NPC1 O15118 1/20 0.40
GAA P10253 1/20 0.40
RAB9A P51151 1/20 0.40
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
PRKCQ Q04759 4/20 0.39
GRM4 Q14833 1/20 0.38
BRAF P15056 1/20 0.38
BCDIN3D Q7Z5W3 1/20 0.37
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4392529 0.90 MAPT (0.48) MAPTALDH1A1DYRK1ACLK4SIRT5
SCHEMBL4380349 0.85 MAPT (0.55) MAPTALDH1A1SIRT5NPC1GAA
SCHEMBL4385085 0.85 PRKCQ (0.54) DYRK1AHDAC3HDAC1HDAC2HDAC6
SCHEMBL1181871 0.83 MAPT (0.47) MAPTALDH1A1SIRT5NPC1RAB9A
SCHEMBL4384924 0.78 MAPT (0.54) MAPTPOLBSIRT5PRKCQMAPK1
SCHEMBL4389712 0.76 PRKCQ (0.54) DYRK1APRKCQ
SCHEMBL4383230 0.74 SIRT5 (0.59) MAPTALDH1A1SIRT5
SCHEMBL1182313 0.74 SIRT5 (0.59) MAPTALDH1A1SIRT5
SCHEMBL4384306 0.74 PRKCQ (0.53) PRKCQ
SCHEMBL1181753 0.74 SIRT5 (0.48) MAPTSIRT5PRKCQ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2066665-A2 BICYCLIC NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS FOR USE AS STEAROYL COA DESATURASE INHIBITORS CV THERAPEUTICS, INC. (US) 2009-06-10 EP disclosed
WO-2008043087-A2 BICYCLIC NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS FOR USE AS STEAROYL COA DESATURASE INHIBITORS CV THERAPEUTICS, INC. (US) 2008-04-10 WO disclosed